BSGSX
Price
$17.62
Change
+$0.10 (+0.57%)
Updated
Jan 17 closing price
Net Assets
195.78M
PMAQX
Price
$45.60
Change
+$0.28 (+0.62%)
Updated
Jan 17 closing price
Net Assets
29.35B
Ad is loading...

BSGSX vs PMAQX

Header iconBSGSX vs PMAQX Comparison
Open Charts BSGSX vs PMAQXBanner chart's image
Baird Small/Mid Cap Growth Investor
Price$17.62
Change+$0.10 (+0.57%)
VolumeN/A
Net Assets195.78M
Principal MidCap R6
Price$45.60
Change+$0.28 (+0.62%)
VolumeN/A
Net Assets29.35B
BSGSX vs PMAQX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BSGSX vs. PMAQX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSGSX is a Hold and PMAQX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 29.3B vs. BSGSX (196M). PMAQX pays higher dividends than BSGSX: PMAQX (0.10) vs BSGSX (0.00). BSGSX was incepted earlier than PMAQX: BSGSX (6 years) vs PMAQX (8 years). BSGSX is a more actively managed with annual turnover of: 48.00 vs. PMAQX (10.10). PMAQX has a lower initial minimum investment than BSGSX: PMAQX (0) vs BSGSX (2500). PMAQX annual gain was more profitable for investors over the last year : 19.96 vs. BSGSX (15.16). PMAQX return over 5 years is better than : 41.71 vs. BSGSX (38.85).
BSGSXPMAQXBSGSX / PMAQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years8 years-
Gain YTD4.0142.173185%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets196M29.3B1%
Annual Yield % from dividends0.000.10-
Returns for 1 year15.1619.9676%
Returns for 3 years1.7320.538%
Returns for 5 years38.8541.7193%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GREE1.910.18
+10.40%
Greenidge Generation Holdings
BCS14.260.27
+1.93%
Barclays PLC
PFSI107.620.97
+0.91%
PennyMac Financial Services
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin